New blood test may reduce transfusions in liver transplants
NCT ID NCT02352181
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 82 adults getting a liver transplant to see if using a special blood test called ROTEM helps doctors manage bleeding better than standard tests. The goal was to see if ROTEM could reduce the amount of blood products given during surgery. Researchers tracked complications like breathing problems, blood clots, and infections to see if the approach was safer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital de la Croix Rousse
Lyon, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scans could uncover silent damage in liver patients awaiting transplant
- A machine that keeps donor livers alive outside the body — could it transform transplantation?
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?
- Frailty test could predict who survives liver transplant waiting list
- Blood type no barrier? study tests liver transplant success across ABO barriers
- Could a single infusion of 'Trainer' cells free liver transplant patients from lifelong drugs?